Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative ReviewReview Published on 2023-11-242024-09-05 Journal: Vaccines [Category] update2024, [키워드] breakthrough children failure Infants pneumococcal Pneumonia Vaccine [DOI] 10.3390/vaccines11121750 PMC 바로가기 [Article Type] Review
ASVAC2022 : 8 th Asian Vaccine ConferenceLicensed Vaccines Published on 2023-01-192024-09-04 Journal: Human vaccines & immunotherapeutics [Category] 대상포진, [키워드] advocacy Asia cholera communication COVID Dengue equity human Papilloma virus immunization Influenza life-course immunization national immunization programme pneumococcal polio pooled procurement respiratory syncytial virus rotavirus typhoid Vaccine confidence Vaccine hesitancy Vaccines [DOI] 10.1080/21645515.2023.2165360 PMC 바로가기 [Article Type] Licensed Vaccines
Knowledge of, and attitudes towards, adult vaccination among General Practitioners in Piedmont, Italy: results from a cross-sectional studyArticle Published on 2022-12-312024-09-08 Journal: Ann Ig [Category] 백일해, [키워드] and herpes zoster (HZ) vaccines at various ages. Background: "Life-course immunization" is increasingly recognized as important. In Italy, adults are recommended to receive influenza pneumococcal tetanus toxoid, reduced diphtheria toxoid, acellular pertussis (Tdap) PMC 바로가기
Factors and Reasons for Non-vaccination among Patients with Systemic Lupus Erythematosus: A Single-centre, Cross-sectional StudyOriginal Article Published on 2022-12-282024-09-04 Journal: Internal medicine (Tokyo, Japan) [Category] 대상포진, [키워드] herpes zoster Influenza pneumococcal systemic lupus erythematosus Vaccine [DOI] 10.2169/internalmedicine.1067-22 PMC 바로가기 [Article Type] Original Article
Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination—statistical analysis plan폐렴구균 백신 일정(PVS) 연구: 폐렴구균 결합 백신에 대한 대체 일정과 표준 일정의 비열등성을 평가하는 집단 무작위 시험—통계 분석 계획Article Published on 2022-12-282024-07-28 Journal: Trials [Category] 폐렴구균 감염증, [키워드] Cluster-randomised pneumococcal schedule Statistical analysis plan Vaccine [DOI] 10.1186/s13063-022-06900-x PMC 바로가기
Adult immunization practices, challenges and opportunities in Central America and the Caribbean: Advisory board proceedingsPublic Health Published on 2022-12-052024-09-04 Journal: Human vaccines & immunotherapeutics [Category] 대상포진, [키워드] Adult immunizations Caribbean Central America hepatitis B herpes zoster Influenza pneumococcal TD Tdap Vaccines [DOI] 10.1080/21645515.2022.2129236 PMC 바로가기 [Article Type] Public Health
Influenza and pneumococcal vaccination and COVID-19 in kidney transplant patientsResearch article Published on 2022-12-012022-10-05 Journal: Transplant immunology [Category] 변종, 진단, 치료제, [키워드] addition administration benefit Clinical course control group COVID COVID-19 COVID-19 infection disease Donor dysfunction examined follow-up time group Hospital stay Hospitalization increased the risk Influenza Influenza and pneumoccal vaccine intensive care kidney transplant kidney transplant recipient lack Logistic regression analysis median multivariate need for dialysis no significant difference observation outcome pandemic Patient pneumococcal positive recipient reduce Result risk of COVID-19 rRT-PCR test significantly higher the disease the patient vaccination vaccination rate Vaccine Vaccines with COVID-19 [DOI] 10.1016/j.trim.2022.101693 [Article Type] Research article
Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiencyArticle Published on 2022-09-142022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료기술, [키워드] activity Adverse reaction analyzed Anti-SARS-CoV-2 S antibody Antibody Response Autoimmune Autoimmune diseases B-lymphocytes Cell Cohort cohort of patient comparable Course COVID-19 COVID-19 vaccination CVID deficiency detect Disease activity dysfunction effective Efficacy and safety Elecsy flow cytometry healthy control humoral humoral immune response Hypogammaglobulinemia IFN-gamma immune system Immunity immunization immunoassay immunodeficiency immunoglobulin replacement therapy in healthy individuals increased risk individual Interferon-gamma lymphocyte neutralization Patient Phenotyping pneumococcal provide reactogenicity receptor Safe SARS-COV-2 infection selective Seven subjects Support syndrome T cell response T-lymphocites the disease triggering underlying disease vaccination vaccine response Vero E6 Virus neutralization was performed well X-linked agammaglobulinemia XLA [DOI] 10.3389/fimmu.2022.974987 PMC 바로가기
Utilization of preventive services in a systemic lupus erythematosus population-based cohort: a Lupus Midwest Network (LUMEN) studyarticle Published on 2022-09-012024-09-02 Journal: Arthritis Research & Therapy [Category] 대상포진, [키워드] Cancer screening cardiovascular risk diabetes DXA Influenza Osteoporosis pneumococcal Preventive services systemic lupus erythematosus Vaccine Zoster [DOI] 10.1186/s13075-022-02878-8 PMC 바로가기 [Article Type] article
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial중국에서 4가 스플릿-비리온 비활성화 인플루엔자 백신 및 23가 폐렴구균 다당류 백신과 함께 투여된 비활성화 SARS-CoV-2 백신(Sinopharm BBIBP-CorV)의 면역원성 및 안전성: 다기관, 비열등성, 공개 라벨, 무작위, 통제, 4상 시험Clinical Trial Published on 2022-08-262022-09-12 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] 23-valent pneumococcal polysaccharide vaccine Administered antibody assigned BBIBP-CorV block randomization blood sample China Coadministration Community dose eligible GMC GMT GMT ratio had no IgG antibody immunogenicity inactivated Inactivated SARS-CoV-2 vaccine individual Influenza Influenza virus multicentre non-inferiority Open-label participant per-protocol population pneumococcal Pneumonia polysaccharide polysaccharide vaccine randomised randomised controlled trial Randomly recruited Registered Safe SARS-CoV-2 SARS-CoV-2 neutralising antibody SARS-CoV-2 vaccine seroconversion rate serotypes Sinopharm Split-virion inactivated influenza vaccine. strain stratified Streptococcus pneumoniae the SARS-CoV-2 three group Trial vaccination Vaccine vaccine group [DOI] 10.1016/j.vaccine.2022.07.033 PMC 바로가기 [Article Type] Clinical Trial